Día Mundial del Riñón 2016, evitando el legado de la enfermedad renal, con enfoque en la niñez
PDF ()
HTML ()

Cómo citar

1.
Ingelfinger JR, Kalantar-Zadeh K, Schaefer F. Día Mundial del Riñón 2016, evitando el legado de la enfermedad renal, con enfoque en la niñez. Rev Nefrol Dial Traspl. [Internet]. 28 de abril de 2017 [citado 3 de diciembre de 2021];36(1):1-. Disponible en: https://www.revistarenal.org.ar/index.php/rndt/article/view/49

Resumen

El Día Mundial del Riñón 2016 se enfoca en las enfermedades renales durante la infancia y en los antecedentes de la enfermedad renal del adulto que puede iniciar en la edad temprana. La Enfermedad Renal Crónica (ERC) en la infancia difiere de la de los adultos en que predominan las causas derivadas de anomalías congénitas y trastornos hereditarios, siendo poco frecuentes las glomerulopatías y la enfermedad renal asociada a diabetes. Adicionalmente, muchos niños con Injuria Renal Aguda pueden eventualmente desarrollar secuelas que lleven a hipertensión y ERC durante la adolescencia o la vida adulta. Los niños nacidos prematuros o pequeños para la edad gestacional tienen un incremento del riesgo para desarrollar ERC durante su vida. Personas con alto riesgo al nacer o en la primera infancia, deberán ser monitorizadas estrechamente para ayudar a detectar a tiempo signos tempranos de enfermedad renal a fin de proporcionar una prevención o tratamiento efectivos. Una terapia exitosa es factible para niños con ERC avanzada; existe evidencia que demuestra que los niños evolucionan mejor que los adultos cuando reciben terapia de reemplazo renal, incluyendo diálisis y trasplante, aunque solo una minoría de los niños puede requerir este tratamiento. Debido a las inequidades en el acceso a la atención médica, es necesario hacer un esfuerzo para que los niños con enfermedad renal, donde sea que vivan, puedan ser tratados de manera eficaz, independientemente de su ubicación geográfica y situación y económica. Nuestra esperanza es que el Día Mundial del Riñón pueda informar al público en general, a los tomadores de decisiones y a los profesionales de la salud, sobre las necesidades y las posibilidades que existen alrededor de la enfermedad renal en la infancia.

PDF ()
HTML ()

Citas

Goldstein SL. Acute kidney injury in children and its potential consequences in adulthood. Blood Purif. 2012;33(1-3):131-7.

Harambat J, Van Stralen KJ, Kim JJ, Tizard EJ. Epidemiology of chronic kidney disease in children. Pediatr Nephrol. 2012;27(3):363-73.

Warady BA, Chadha V. Chronic kidney disease in children: the global perspective. Pediatr Nephrol. 2007;22(12):1999-2009.

Furth SL, Cole SR, Moxey-Mims M, Kaskel F, Mak R, Schwartz G, et al. Design and methods of the Chronic Kidney Disease in Children (CKiD) prospective cohort study. Clin J Am Soc Nephrol. 2006;1(5):1006-15.

Health Statistics and Information Systems, World Health Organization. Global Health Estimates for the years 2000-2012. Disponible en: http://www.who.int/healthinfo/global_burden_disease/estimates/en/index1.html

North American Pediatric Renal Trials and Collaborative Studies Annual Reports. Disponible en: https://web.emmes.com/study/ped/annlrept/annlrept.html

Saran R, Li Y, Robinson B, Ayanian J, Balkrishnan R, Bragg-Gresham J, et al. US Renal Data System 2014 Annual Data Report: Epidemiology of Kidney Disease in the United States. Am J Kidney Dis. 2015;66(1Suppl 1):S1-305.

ESPN/ERA-EDTA Registry, European Registry for Children on Renal Replacement Therapy. Disponible en: http://www.espn-reg.org/index.jsp

Ardissino G, Daccò V, Testa S, Bonaudo R, Claris-Appiani A, Taioli E, et al. Epidemiology of chronic renal failure in children: data from the ItalKid project. Pediatrics. 2003;111(4 Pt 1):e382-7.

Wong CJ, Moxey-Mims M, Jerry-Fluker J, Warady BA, Furth SL. CKiD (CKD in children) prospective cohort study: a review of current findings. Am J Kidney Dis. 2012;60(6):1002-11.

Vos T, Barber RM, Bell B, Bertozzi-Villa A, Biryukov S, Bolliger I, et al. Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2015;386(9995):743-800.

Coca SG, Singanamala S, Parikh CR. Chronic kidney disease after acute kidney injury: a systematic review and meta-analysis. Kidney Int. 2012;81(5):442-8.

Basu RK, Kaddourah A, Terrell T, Mottes T, Arnold P, Jacobs J, et al. Assessment of Worldwide Acute Kidney Injury, Renal Angina and Epidemiology in critically ill children (AWARE): study protocol for a prospective observational study. BMC Nephrol. 2015;16:24.

Eckardt KU, Coresh J, Devuyst O, Johnson RJ, Köttgen A, Levey AS, et al. Evolving importance of kidney disease: from subspecialty to global health burden. Lancet. 2013;382(9887):158-69.

Wühl E, Van Stralen KJ, Verrina E, Bjerre A, Wanner C, Heaf JG, et al. Timing and outcome of renal replacement therapy in patients with congenital malformations of the kidney and urinary tract. Clin J Am Soc Nephrol. 2013;8(1):67-74.

ESCAPE Trial Group, Wühl E, Trivelli A, Picca S, Litwin M, Peco-Antic A, et al. Strict blood-pressure control and progression of renal failure in children. N Engl J Med. 2009;361(17):1639-50.

Van Stralen KJ, Borzych-Dużalka D, Hataya H, Kennedy SE, Jager KJ, Verrina E, et al. Survival and clinical outcomes of children starting renal replacement therapy in the neonatal period. Kidney Int. 2014;86(1):168-74.

Querfeld U, Anarat A, Bayazit AK, Bakkaloglu AS, Bilginer Y, Caliskan S, et al. The Cardiovascular Comorbidity in Children with Chronic Kidney Disease (4C) study: objectives, design, and methodology. Clin J Am Soc Nephrol. 2010;5(9):1642-8.

Hoy WE, Ingelfinger JR, Hallan S, Hughson MD, Mott SA, Bertram JF. The early development of the kidney and implications for future health. J Dev Orig Health Dis. 2010;1(4):216-33.

Flynn JT, Ng DK, Chan GJ, Samuels J, Furth S, Warady B, et al. The effect of abnormal birth history on ambulatory blood pressure and disease progression in children with chronic kidney disease. J Pediatr. 2014;165(1):154-162.e1.

Rodríguez MM, Gómez AH, Abitbol CL, Chandar JJ, Duara S, Zilleruelo GE. Histomorphometric analysis of postnatal glomerulogenesis in extremely preterm infants. Pediatr Dev Pathol. 2004;7(1):17-25.

Abitbol CL, Bauer CR, Montané B, Chandar J, Duara S, Zilleruelo G. Long-term follow-up of extremely low birth weight infants with neonatal renal failure. Pediatr Nephrol. 2003;18(9):887-93.

Hodgin JB, Rasoulpour M, Markowitz GS, D’Agati VD. Very Low Birth Weight is a Risk Factor for Secondary Focal Segmental Glomerulosclerosis. Clin J Am Soc Nephrol. 2009;4(1):71-6.

Verhave JC, Wetzels JF, Van de Kar NC. Novel aspects of atypical haemolytic uraemic syndrome and the role of eculizumab. Nephrol Dial Transplant. 2014;29(Suppl 4):iv131-41.

Torres VE. Vasopressin receptor antagonists, heart failure, and polycystic kidney disease. Annu Rev Med. 2015;66:195-210.

Jarzembowski T, John E, Panaro F, Heiliczer J, Kraft K, Bogetti D, et al. Impact of non-compliance on outcome after pediatric kidney transplantation: an analysis in racial subgroups. Pediatr Transplant. 2004;8(4):367-71.

Watson AR. Non-compliance and transfer from paediatric to adult transplant unit. Pediatr Nephrol. 2000;14(6):469-72.

Aujoulat I, Deccache A, Charles AS, Janssen M, Struyf C, Pélicand J, et al. Non-adherence in adolescent transplant recipients: the role of uncertainty in health care providers. Pediatr Transplant. 2011;15(2):148-56.

Watson AR, Harden PN, Ferris ME, Kerr PG, Mahan JD, Ramzy MF, et al. Transition from pediatric to adult renal services: a consensus statement by the International Society of Nephrology (ISN) and the International Pediatric Nephrology Association (IPNA). Kidney Int. 2011;80(7):704-7.

Watson AR, Harden P, Ferris M, Kerr PG, Mahan J, Ramzy MF. Transition from pediatric to adult renal services: a consensus statement by the International Society of Nephrology (ISN) and the International Pediatric Nephrology Association (IPNA). Pediatr Nephrol. 2011;26(10):1753-7.

Gallieni M, Aiello A, Tucci B, Sala V, Brahmochary Mandal SK, Doneda A, et al. The burden of hypertension and kidney disease in Northeast India: the Institute for Indian Mother and Child noncommunicable diseases project. ScientificWorldJournal. 2014;2014:320869.

White A, Wong W, Sureshkumur P, Singh G. The burden of kidney disease in indigenous children of Australia and New Zealand, epidemiology, antecedent factors and progression to chronic kidney disease. J Paediatr Child Health. 2010;46(9):504-9.

Zarocostas J. Need to increase focus on noncommunicable diseases in global health, says WHO. BMJ. 2010;341:c7065.

Gulland A. WHO agrees to set up body to act on non-communicable diseases. BMJ. 2013;346:f3483.

Feehally J. Chronic kidney disease: Health burden of kidney disease recognized by UN. Nat Rev Nephrol. 2011;8(1):12-3.

Couser WG, Remuzzi G, Mendis S, Tonelli M. The contribution of chronic kidney disease to the global burden of major noncommunicable diseases. Kidney Int. 2011;80(12):1258-70.